Aurobindo Pharma Ltd - Company Profile
Powered by 
All the sales intelligence you need on Aurobindo Pharma Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Aurobindo Pharma Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Aurobindo Pharma Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Aurobindo Pharma Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390254A1 | Application | Pharmaceutical compositions of ubrogepant and process for preparation thereof | A61K31/437; A61K9/2009; A61K9/2013; A61K9/2018; A61K9/2027; A61K9/2031; A61K9/2054 | December 07, 2023 |
| EP4021920A4 | Search Report | Verbessertes verfahren zur herstellung von etelcalcetid-hydrochlorid | A61P5/18; A61P5/20; C07K7/06 | August 16, 2023 |
| US20230248667A1 | Application | Extended release compositions of pseudoephedrine or its pharmaceutically acceptable salt thereof | A61K31/135; A61K31/137; A61K31/495; A61K9/2054; A61K9/209; A61K9/282; A61K9/284; A61K9/2866; A61K9/2886; A61K9/2893 | August 10, 2023 |
| WO2023126821A1 | Application | C1q binding assay | G01N2333/4716; G01N33/54373; G01N33/557 | July 06, 2023 |
| IN202141055178A | Application | A novel process for the preparation of 3cl protease inhibitor (NIRMATRELVIR) | June 02, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer